Literature DB >> 1757394

Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.

G Frykholm1, B Glimelius, S Richter, J Carlsson.   

Abstract

A panel of human colon carcinoma cell lines were characterized regarding both antigenic heterogeneity and variations in radiosensitivity. Monoclonal antibodies were used to study the expression of carcinoembryonic antigen (CEA), gastrointestinal cancer antigen (GICA or CA 19-9) and carcinoma-associated antigen (CA-50). Radiosensitivity was studied with the clonogenic survival technique. Three cell lines, LS 174T, HCTC, and SW 1116 stained positive for all three antigens. HT-29 was positive for CA 19-9 and CA-50 whereas Caco-2 was positive for CEA and CA 19-9. The cell lines SW 620 and LIM 1215 only stained positive for one of the antigens, CA-50 and CEA, respectively. In nearly all positive cases the stainings were very heterogeneous with mixtures of positive and negative cells. One exception was the HCTC cells which stained homogeneously for the CA 19-9 and CA-50 antigens. The neuroendocrinelike COLO 320 cells were negative in all cases. The radiosensitivity varied strongly between the cell lines with Dq-values between 0.8 and 1.9, extrapolation numbers between 2.0 and 4.7, Do-values between 1.1 and 2.8. The surviving fraction at 2 Gy varied between 0.3 and 0.7 with HCTC as the most radiosensitive and HT-29 as the most radioresistant cell line. Thus, there were differences in antigenic expression and intrinsic radiosensitivity between the cell-lines and antigenic heterogeneities within each cell line. The analyzed panel of cell lines will be valuable in studies of dose-effect relations for monoclonal antibodies labeled with toxic radionuclides simulating both antigenic heterogeneity and variations in radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757394     DOI: 10.1007/bf02631115

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  48 in total

1.  Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.

Authors:  R M Sharkey; F A Kaltovich; L B Shih; I Fand; G Govelitz; D M Goldenberg
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

2.  Preoperative irradiation of primarily non-resectable adenocarcinoma of the rectum and rectosigmoid.

Authors:  L Påhlman; B Glimelius; C Ginman; S Graffman; B Adalsteinsson
Journal:  Acta Radiol Oncol       Date:  1985 Jan-Feb

3.  Suppression of the growth of human colorectal carcinoma cells (LS174T) by radiolabeled monoclonal antibody (131I-MAbC27) in tissue culture and nude mice.

Authors:  L C Tsai; J K Lin; S H Han; H M Chen
Journal:  Dis Colon Rectum       Date:  1988-10       Impact factor: 4.585

4.  The spatial distribution of parenterally administered monoclonal antibodies against CEA in a human colorectal tumour xenograft.

Authors:  H Ahlström; P Enblad; A Andersson; L E Lörelius
Journal:  Acta Oncol       Date:  1989       Impact factor: 4.089

5.  Imaging of colon carcinoma with 111-indium-labeled anti-CEA monoclonal antibodies (Indacea) prior to surgery.

Authors:  J D Beatty; V J Philben; B G Beatty; L E Williams; R J Paxton; J E Shively; R B Duda; W G Vlahos; J L Werner; K Sheibani
Journal:  J Surg Oncol       Date:  1987-10       Impact factor: 3.454

6.  A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer.

Authors:  R H Whitehead; F A Macrae; D J St John; J Ma
Journal:  J Natl Cancer Inst       Date:  1985-04       Impact factor: 13.506

7.  Irradiation and surgery of primarily inoperable rectal adenocarcinoma.

Authors:  T Bjerkeset; O Dahl
Journal:  Dis Colon Rectum       Date:  1980 Jul-Aug       Impact factor: 4.585

Review 8.  Role of carcinoembryonic antigen assay in the management of cancer.

Authors:  P H Sugarbaker
Journal:  Adv Immun Cancer Ther       Date:  1985

9.  Antigenic heterogeneity and individuality in adenocarcinomas of the rectum and their secondaries.

Authors:  P Enblad; B Glimelius; C Busch; J Pontén; L Påhlman
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

10.  Characterization of human colon carcinoma cell lines isolated from a single primary tumour.

Authors:  M G Brattain; M E Marks; J McCombs; W Finely; D E Brattain
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

View more
  5 in total

Review 1.  Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance.

Authors:  Greg M Thurber; Michael M Schmidt; K Dane Wittrup
Journal:  Adv Drug Deliv Rev       Date:  2008-04-24       Impact factor: 15.470

2.  Combination of gold nanoparticles with low-LET irradiation: an approach to enhance DNA DSB induction in HT29 colorectal cancer stem-like cells.

Authors:  Mahdi Abbasian; Azam Baharlouei; Zahra Arab-Bafrani; David A Lightfoot
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-19       Impact factor: 4.553

3.  A systems approach for tumor pharmacokinetics.

Authors:  Greg Michael Thurber; Ralph Weissleder
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

4.  Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.

Authors:  Jörgen Carlsson; Veronika Eriksson; Bo Stenerlöw; Hans Lundqvist
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-23       Impact factor: 9.236

5.  Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity.

Authors:  Qing Pan; Carmen O K Law; Mingo M H Yung; K C Han; Yuen Lam Pon; Terrence Chi Kong Lau
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.